Related by context. All words. (Click for frequent words.) 74 approval 63 Approvals 61 Final Approval 60 Approved 60 Conditional Approval 58 approvals 57 Obtains Regulatory 56 Approving 56 approved 55 Authorization 54 Regulatory Approval 53 Resubmission 53 Approve 53 Rejection 53 ap proval 53 Recommends Approval 52 Approvable 52 regulatory approval 52 Clearance 51 Clears Way 51 Expedited Review 51 approve 51 Votes Unanimously 50 Acceptance 50 Preliminary Approval 50 Tentative Approval 50 Designation 50 Accelerated Assessment 50 Shareholder Approval 50 Finalization 49 PTPA Media Seal 49 Fast Track Status 49 Completion 49 Rejects Proposed 49 Orphan Designation 49 Approval Process 49 Regulatory Approvals 49 Finalizing 48 approving 48 License Application 48 Submits Application 48 OK'd 48 Marketing Authorization 48 Vesting Order 48 Antitrust Immunity 48 Positive Opinion 48 Premarket Approval 48 Regulate Tobacco 48 Clears Path 48 Receives Tentative FDA 48 Overrides 48 Wins Approval 48 Fast Track Designation 47 Clears Hurdle 47 authorizations 47 Regulatory Clearance 47 Marketing Authorisation 47 Orphan Status 47 FDA Approval 47 Unanimously Recommends 47 Listing Approval 47 Principle AIP 47 Taro Receives 47 Receives Approval 47 Receives Permit 47 APMA Seal 47 #k Clearance 47 liver resection surgeries 47 Approves 47 Resubmits 47 Order Authorizing 47 Gives Nod 47 Permission 47 APPROVAL 47 reapproval 47 Gets Approval 46 authorization 46 Unanimously Approves 46 Obtains CE Mark 46 Expanded Indication 46 reapprove 46 Antitrust Clearance 46 Specific Use Permit 46 Ratification 46 Unanimous Approval 46 Proxy Proposals 46 Waiver Request 46 Panel Rejects 46 Conditional Listing 46 PDUFA Date 46 Accelerated Approval 46 Proposed Rule Changes 46 PTPA Seal 46 Substantial Completion 46 Loan Guarantees 46 Receives Approval From 46 Orphan Drug Status 46 Confirmation 46 Panel Backs 46 Authorisation 46 Proposed 46 Awaits Approval 46 Postpones Decision 46 VIVUS Announces 46 Miraculins Announces 46 Reauthorize 46 Gets Tentative 45 Surfaxin lucinactant 45 Combined License Application 45 Antitrust Approval 45 STERIS Corporation Announces 45 FDA Panel Recommends 45 Occupancy Permit 45 Accreditation 45 orphan designation 45 NYSE Amex Listing 45 Fast Tracked 45 Obtains FDA 45 Conditional 45 Fast Track designations 45 Panel Votes 45 Denies Petition 45 Endorsement 45 Reappointments 45 Denies Bid 45 OMP designation 45 Authorizations 45 Propose Changes 45 License Renewal 45 Certification 45 Pared Down 45 Secretaria de Recursos Naturales 45 NDA Submission 45 Approves Merger 44 Panel Considers 44 PMA Supplement 44 Biologic License Application 44 Lupus Drug 44 Conditionally 44 Orphan Drug Designation 44 Finalized 44 Stockholder Approval 44 Grants Orphan Drug 44 conditionally approved 44 Cervical Cancer Vaccine 44 Rehearing 44 Decision Delayed 44 Gets Thumbs Down 44 Competitive Bids 44 Receives Favorable 44 Approves Controversial 44 Satellite Radio Merger 44 Supermajority 44 Approves Revised 44 Biologic License Application BLA 44 Receives Conditional 44 Preliminary plat 44 Panel Endorses 44 Panel Advises 44 Ephedra Ban 44 Investigational Device Exemption 44 FDA Accepts 44 Pending 44 Trobalt 44 CMDCAS 44 Appears Likely 44 Reexamine 44 ISO Certification 44 OKd 44 Delays Vote 44 Delays Decision 44 Tentatively Approves 44 Okayed 44 Opposes Proposed 43 include Naglazyme 43 Receives Marketing Authorization 43 Subpart E 43 Prostate Cancer Vaccine 43 Unanimous 43 CLIA Waiver 43 Receives Regulatory 43 & Workover Fluids 43 Okays 43 Advisers Urge 43 Psoriasis Drug 43 GRAS Status 43 ratification 43 Overwhelming Support 43 k Clearance 43 Counteroffer 43 Drilling Permit 43 Presidential Assent 43 Permits 43 CHMP Opinion 43 Debated 43 Orphan Drug status 43 FIRAZYR 43 Announce Shareholder Approval 43 Denies Request 43 APPROVED 43 Granted Orphan Drug 43 reapproved 43 CE Marking 43 Nabi HB Intravenous 43 Setback 43 Comment Period 43 Nonproliferation Enhancement Act 43 Favorable Ruling 43 Panel Weighs 43 Reaccreditation 43 Preliminary Injunction Against 43 Risperidone Oral Solution 43 Appropriateness 43 CryoSeal FS System 43 RUS Acceptance 43 Announces Tentative Approval 43 Extend Deadline 43 Confirmatory 43 Renegotiation 43 Submits 43 Prequalification 43 Seeks Approval 43 Rescinded 43 Orphan Drug designation 43 Product Designation 43 Ratifies 43 Shareholder Meeting Date 43 regulatory approvals 42 Receives Positive Opinion 42 Reaches Accord 42 FDA Clearance 42 Approves Settlement 42 Narrowly Approves 42 Receives CE Marking 42 Priority Review 42 Approve Merger 42 Diamyd Medical Diamyd 42 Vote Delayed 42 Nears Vote 42 Misses Deadline 42 Receives Complete Response 42 Comair Pilots 42 Lawmakers Oppose 42 Reject Proposed 42 Medicure Announces 42 y Ambiente SERNA Honduras 42 sevenths majority 42 Announce Receipt 42 Sirius XM Merger 42 Voluntary Withdrawal 42 Rulemaking 42 RP Rating 42 Approves Sale 42 Urges Rejection 42 Final Plat 42 Proposal 42 Permit Approval 42 Receives Approvals 42 EDQM 42 Postpones Vote 42 Considers Extending 42 Proposed Reorganization 42 Designations 42 Submits Revised 42 Leans Toward 42 GMP Certification 42 Withdraws Application 42 Ratified 42 IDE Investigational Device Exemption 42 Rejects Bid 42 Recommends Changes 42 cytokine immunomodulator 42 Veto Override 42 ANVISA 42 Override Veto 42 Company LUMA imaging 42 assent 42 Renews Push 42 Receives Clearance 42 TELEC 42 appro val 42 Dealt Setback 42 Panel Urges 42 Modifies 42 Imported Drugs 42 Blood Pressure Drug 42 Contrave NDA 42 Highest Rating 42 Unsolicited Acquisition 42 Listing Compliance 42 Unanimous Vote 42 Reconsiders 42 Poll Shows Support 42 Resubmit 42 Panel Recommends 42 Environmental Compatibility 42 Milestone Payment From 42 Renegotiates 42 Stronger Warnings 42 Recertification 42 IND Application 42 Legislation Introduced 42 Hits Roadblock 42 Becomes Effective 42 Categorical Exclusion 42 Receives Stockholder Approval 42 Supplemental Biologics License Application 42 Alair System 42 Rezoning Request 42 Deeply Disappointed 42 Rescind 42 Biologics Licensing 42 NerPharMa 42 Bipartisan Support 42 Gets Mixed Reviews 42 Land Use Permit 41 Receives CE 41 Rejects Proposal 41 Velaglucerase Alfa 41 Holds Hearings 41 Panel Approves 41 Generic Versions 41 Bidding Procedures 41 Type Approval 41 IND Filing 41 Overrules 41 Overwhelming Response 41 Pre IND 41 Considers Delaying 41 Withdrawal 41 Expansion 41 Referendum Petition 41 Hurdles Loom 41 Sweetened Offer 41 Approve Proposed 41 Permit 41 Deliberates 41 Voters Reject 41 Wage Freeze 41 Senators Criticize 41 Proposals 41 Biophan patent 41 Orphan designation 41 Consummation 41 Extends Deadline 41 Ratifying 41 Rejects Request 41 Rejects Effort 41 Court Overrules 41 Fuwei Films Announces 41 Trade Relations PNTR 41 Temporary Reprieve 41 Commissioners Approve 41 antitrust clearance 41 Cinacalcet HCl 41 Acquire Controlling Stake 41 Submits Investigational 41 NexMed Receives 41 Binding Offer 41 Receives Regulatory Approvals 41 EASA approvals 41 Panel Mulls 41 ISO #:# Certification [001] 41 Scientific Advice 41 CHMP recommendation 41 Reaches Tentative 41 Issues Complete Response 41 Approvable Letter 41 Defers Decision 41 biosimilar filgrastim 41 Variances 41 Ratify 41 CLIA waiver 41 Lacks Votes 41 Accreditations 41 Conformite Europeene 41 Finalised 41 Testosterone Patch 41 EASA certification 41 Marketing Authorisation Application 41 Refile 41 NESINA 41 regulatory clearances 41 Creditor Protection 41 Submits Final 41 Patent Covering 41 Troop Withdrawal 41 Regulatory Filing 41 Pushes Ahead 41 Legislation Passes 41 Debate Heats Up 41 Files Investigational 41 Remain Listed 41 Regulators Approve 41 IOSA Registration 41 Panel Nixes 41 Permanent Injunction Against 41 Symbol Symbole 41 Lambert Eaton Myasthenic 41 Narrowly Passes 41 Cloning Ban 41 OKs 41 ZTEST Announces 41 Waste Discharge 41 ISO #:# Certification [002] 41 Ownership Rules 41 FDA Orphan Drug 41 Winner Notification 41 Stockholder Vote 41 Draws Mixed Reviews 41 Proposes Changes 41 disinterested shareholder 41 Nears Approval 41 Dispute Settled 41 Moves Forward 41 XXX Domain 41 Important Milestone 41 Groups Oppose 41 Stock Buyback Plan 41 Considers Changing 41 certification 40 Glaxo Cervarix 40 Shonin approval 40 CCHIT Certification 40 Vetoes 40 approves 40 Naglazyme ® galsulfase 40 Seeks Tougher 40 Unanimously Passes 40 Pave Way 40 Withdraws Request 40 Shingles Vaccine 40 ONGLYZA ™ 40 Deadline Approaches 40 Million Settlement Preliminarily 40 Generic Version Of 40 Decide Fate 40 Merger Proposal 40 Bylaw Amendments 40 FDA Approvable Letter 40 Disapproval 40 Funding 40 Non Binding 40 Genetically Modified Salmon 40 Angiox ® 40 GTC recombinant form 40 Whitewash Waiver 40 Permit Application 40 Receives Orphan Drug Designation 40 Suit Seeks 40 UIC Permit 40 clearance 40 Unanimous approval 40 Lorus Therapeutics Announces 40 Compromise Reached 40 Terminate Merger 40 NASDAQ Delisting Notice 40 Submits Biologics License Application 40 Rejects Attempt 40 Overwhelmingly Approve 40 Debt Swap 40 Signs Binding Agreement 40 Senate Panel Approves 40 Offshore Drilling Ban 40 Takeover Bids 40 Statewide Smoking Ban 40 Fee Hike 40 received CE Conformite 40 Temporary Closure 40 Orphan Drug designations 40 NAMENDA 40 Ok'd 40 Regain Compliance With 40 Tax Exemption 40 trans Atlantic antitrust immunity 40 Rescinds 40 Submits NDA 40 Pregabalin 40 Preliminary Plat 40 Completed 40 Ranolazine 40 User Fee Act 40 Drug Approvals 40 Silicone Breast Implants 40 Disapprove 40 Inhaled Insulin 40 Restricts Access 40 Schematic Design 40 Reaffirms Support 40 Reorganization Confirmed 40 Seeks Clarification 40 Testosterone Gel 40 CoPP 40 Moves Ahead 40 Proposed Legislation 40 Reconstitute 40 Recusal 40 Lawmakers Reject 40 Visa PED 40 CPCN 40 Conditional Use 40 Lumera stockholders 40 Negotiators Agree 40 Veto Threat 40 Subpart H 40 Voluntary Delisting 40 Sertraline Hydrochloride Tablets 40 Theratechnologies Announces 40 Lawsuit Challenging 40 Gives Thumbs Up 40 Sweeping Changes 40 Trade Pact 40 Confirms Receipt 40 Unanimously 40 Hits Snag 40 Readied 40 Paves Way 40 DIP Loan 40 IOSA registration 40 Reverses Decision 40 Tabled 40 Special Exception 40 Gout Drug 40 Gives Thumbs Down 40 Patent Reexamination 40 Drug Fails 40 conditional inter alia 40 Rejected 40 Asset Swap 40 Submits Supplemental 40 OK'ed 40 Arzerra ofatumumab 40 Abortion Restrictions 40 Bid Update3 40 Receipt 40 Greenhouse Gas Emissions Trading 40 Panel Upholds 40 Effort Fails 40 Would Violate 40 Eases Rules 40 Milestone Payments 40 GMP certification 40 Issues Guidance 40 BioSante Pharmaceuticals Announces 40 Loosens 40 Biological License Application 40 Takes Steps 40 Urges Compromise 40 Conditional Use Permit 40 Receives Authorization 40 Million Milestone Payment 40 Receives Conditional Approval 40 Unsolicited Tender Offer 40 Permit Fees 40 Same Sex Benefits 40 Gets Thumbs Up 40 Be Studied 40 Seeks Input 40 Unions Agree 40 Esbriet ® 40 Deficit Cutting 40 Complies 40 Payment Deadline 40 Injunction Against 40 BPZ Energy Announces 40 Tentative Agreement 40 Obtains Approval 40 Agreement Reached 40 Terminates Contract 40 ENLIGHT 40 Use Commendation 40 submittal 40 okayed 40 Emphasizes Need 40 Drug Application 40 Cash Infusion 40 Shareholder Vote 40 Seeks Buyer 40 Decentralized Procedure DCP 40 ADDERALL XR R 40 Explores Possible 40 Negotiations Continue 40 FDA Okays 40 Audit Faults 40 requisite approvals 39 Move Quickly 39 unanimously approved 39 Cloned Meat 39 designated cethromycin 39 Stipulated Order 39 R galsulfase 39 Breakup Fee 39 Continued Listing 39 Generic Lovenox 39 Authorisations 39 Special Use Permit 39 Removal 39 Suit Challenges 39 Phase III Clinical Trial 39 CEA Applauds 39 Phasing Out 39 Decision 39 Annulment 39 Expands Scope 39 Receives Positive 39 Settle Dispute Over 39 Reaches Pact 39 Adjourns 39 Leaders Applaud 39 Formalizes 39 Finalises 39 Temporary Injunction 39 WDEQ Permit 39 Certifications 39 Pay Hike 39 Deadline Arrives 39 IMPELLA R 39 Strongly Supports 39 Complies With 39 Moves Towards 39 Nuke Waste 39 Pre Emption 39 Spectrum Pharmaceuticals Announces 39 Receives Unsolicited 39 Immigration Overhaul 39 Close Loopholes 39 Submits Response 39 Feds Deny 39 Faces Obstacles 39 To Decide Fate 39 Loan Guarantee 39 Deals Setback 39 Oks 39 Arthritis Drugs 39 Intravenous Formulation 39 Generic Zocor 39 Conformite Europeenne CE 39 Gets Nod 39 CIP TRAMADOL ER 39 Standby Equity 39 Reconvene 39 DORIBAX 39 Terminate Agreement 39 Genzyme Myozyme 39 Would Restrict 39 Mutual Recognition Procedure 39 Patents Covering 39 FTC Clears 39 Naglazyme R galsulfase 39 Increased Scrutiny 39 FOIA Requests 39 Inches Toward 39 AVI BioPharma Announces 39 Environment Impact Statement 39 Pullout 39 Hits Speed Bump 39 Pending Merger 39 Receives Confirmation 39 Marketing Authorisations 39 daily bactericidal antibiotic 39 Generous Donation 39 BioGlue R 39 Senators Urge 39 Generic Version 39 Suit Challenging 39 Recognition 39 Abandons Plans 39 House Panel Approves 39 Lobbying Effort 39 Despite Veto Threat 39 Biotech Firm 39 governmental approvals 39 KEY ACTION 39 Gets Nod From 39 Exploitation Concession 39 Preemption 39 preliminary subdivision plat 39 Strike Authorization 39 Zidovudine Tablets 39 USFDA approval 39 Rate Increase 39 Marketing Authorization Application 39 Sets Deadline 39 Investigational Treatment 39 Orphan Medicinal Product 39 Enacts 39 Deadline Extended 39 Showdown Looms 39 Nears Completion 39 Jobless Benefits 39 Arms Pact 39 Rheumatoid Arthritis Drug 39 Scaled Down 39 Holds Hearing 39 Rejects Unsolicited 39 Unsolicited Proposal 39 WebTech Wireless Announces 39 Partial Settlement 39 Supply Agreements 39 First Step Toward 39 Use Authorization 39 Sidesteps 39 Seasonal Influenza Vaccine 39 receives royal assent 39 Moves Toward 39 Moves Closer 39 k Premarket Notification 39 Debt Repayment 39 Swine Flu Vaccines 39 Hold Hearings 39 Japanese Encephalitis Vaccine 39 Scrutinizes 39 AstraZeneca Seroquel XR 39 donepezil hydrochloride 39 Drilling Permits 39 Brownfield Cleanup 39 granted orphan medicinal 39 PMA submission 39 Underscores Need 39 TABB Group Says 39 Billion Takeover 39 Passes Milestone 39 Hiring Freeze 39 Certican 39 Deals Blow 39 Unsolicited Proposal From 39 Files IND 39 Firdapse ™ amifampridine phosphate 39 Failing Grades 39 Wrangle Over 39 KRYSTEXXA TM 39 Rocmec Closes 39 securityholder approval 39 Gives Tentative 39 Mad Cow Testing 39 Sets Timetable 39 #B Bailout 39 Validation 39 SJ Res 39 Proposed Changes 39 Incidental Take 39 Negotiated Settlement 39 PROVENGE ® 39 Clinical Trial Evaluating 39 Anti Nausea 39 Files Complaint Over 39 Reorganization Plan 39 Considers Expanding 39 Files Petition 39 FIPS #-# Certification 39 Sends Warning 39 Recieves 39 Fast Track designation 39 Warm Reception 39 Order Granting 39 Finds Problems 39 Q#IR 39 Rezone 39 Noriega Extradition 39 Favorable Decision 39 Judicial Nominee 39 Waiting Period 39 Hiberix 39 ZEFTERA ™ 39 authority Gurian Sherman 39 Patent Term 39 Default Notices 39 Rezoning 39 Passage 39 Lawsuit Dismissal 39 Sets Tentative 39 Lawmakers Approve 39 Receives Tentative Approval 39 Talks Stall 39 Receives Fast Track 39 ACCCE Statement Regarding 39 Authorizes 39 Bogs Down 39 Data Suggest 39 Buyback Plan 39 Defers 39 Issues Clarification 39 Indecency Fine 39 Petition Signatures 39 Vote Looms 39 Could Undermine 39 TEMODAL 39 Temporary Waiver 39 Stirs Debate 39 Bill Clears Hurdle 39 Announce Successful Completion 39 Trump Casinos 39 Unanimously Approved 39 Applauds Introduction 39 requisite stockholder 39 Gerdau Ameristeel Announces 39 Methyl Iodide 39 Pivotal Study 39 Lawsuit Settlement 39 BIO Applauds 39 greenlight 39 Dual Listing 39 Initiate Phase II 39 Alexion Soliris 39 InterOil Announces 39 Makes Headway 39 Leaders Agree 39 From Cloned Animals 39 Manufactured Goods 39 Restructure Debt 39 Law Upheld 39 Nortel Obtains 39 Bln Deal 39 Reiterates Support 39 Governor Vetoes 39 Announces Consummation 39 Sales Tax Hike 39 Reforms Needed 39 Higher Doses 39 UL Certification 39 Receives Permission 39 Weight Loss Drug 39 Clifford Whall director 39 Extend Jobless Benefits 39 Ease Restrictions 39 Clears 38 Amgen Nplate 38 Patriot Act Provisions 38 Court Annuls 38 Vetoed 38 Nadcap accreditation 38 Whooping Cough Vaccine 38 Debate Rages 38 rejection 38 Extending Unemployment Benefits 38 Hotly Debated 38 Successful Completion 38 Faces Tough 38 Gay Marriage Amendment 38 Shareholders Approve Proposed 38 Vetos 38 Causes Concern 38 Hails Passage 38 Asset Sale 38 Lawsuit Filed Over 38 Faces Uncertain 38 Delays Ruling 38 EvaMist NDA submission 38 Senators Propose 38 FDA Accelerated Approval 38 Legislation 38 Condemnation 38 Begin Clinical Trials 38 Raise Minimum Wage 38 Reneges 38 Spending Restraint 38 Expanded 38 Lawsuit Involving 38 Discontinuation 38 OKed 38 Passes Legislation 38 Minimum Wage Increase 38 Preliminary Injunction 38 Bargaining Rights 38 Needs Overhaul 38 Billion Stimulus 38 Veterinary Biologics 38 Passes Landmark 38 Eucreas 38 Issues Reminder 38 Receives Approvable Letter 38 Million Convertible Debt 38 Unitholders Approve 38 Adjuvant Treatment 38 Cloture Vote 38 Appeal Ruling 38 Exclusive License 38 Lays Out Plan 38 Abortion Pill 38 Finalising 38 Affirmative Action Ban 38 # Approving 38 Poniard Pharmaceuticals Announces 38 Invalidate 38 Phase III Trial 38 Alvesco R 38 Makes Hostile 38 Binding Arbitration 38 Jobless Benefits Extension 38 Asthma Inhaler 38 Prequalified 38 Requested 38 Parent Tested Parent 38 Long Awaited 38 Deal Reached 38 Fully Subscribed 38 Patent Broadly Covering 38 Directors Unanimously Rejects 38 Risk Minimization Action 38 Reassignment 38 Approves Dividend 38 Greenhouse Gas Emission Trading 38 Strikes Down 38 Contract Renewal 38 resubmits 38 Polls Indicate 38 ISA #.#a standard 38 Swissmedic 38 PDL BioPharma Announces 38 Revokes 38 acceptance 38 Draws Fire 38 Share Issuance 38 Nivestim 38 Announces Delisting 38 ANDA Filing 38 Clearford Announces 38 Ceftobiprole 38 Recurrent Prostate Cancer 38 Early Termination 38 Kid Tested 38 Chilly Reception 38 Meets Primary Endpoint 38 Should Reconsider 38 Seek Input 38 Receives Initial 38 Acquisition Proposal 38 Reach Tentative Contract 38 Market Approval PMA 38 Gets Clearance 38 Lukewarm Response 38 A.#/S.# 38 Prospects Dim 38 Epilepsy Drug 38 Proposed Combination 38 Consideration 38 Groundbreaking 38 necessary regulatory approvals 38 Balance Sheet Restructuring 38 Patient Enrollment 38 Final Stages 38 Tablet Formulation 38 FDA Approves 38 Weighs Options 38 Shareholders Approve Plan 38 FDA Approves Expanded 38 Marketing Approval PMA 38 Nonbinding 38 AAMAC warrantholders 38 Schizophrenia Drug 38 Rate Freeze 38 Desvenlafaxine Succinate 38 Hearings Continue 38 generic Zithromax 38 Ballot Count 38 Groups Applaud 38 Drill Permit 38 Revote 38 Metformin Hydrochloride 38 Emisphere Technologies Announces 38 FDA Approvals 38 Residency Requirements 38 Frequency Allocation 38 Delist 38 Regulatory Overhaul 38 Water Rate Hike 38 Brinavess 38 Issues Statement Regarding 38 Thelin TM 38 Tentative Deal Reached 38 Results Confirm 38 PUC Approves 38 Pivotal Phase III 38 Amends Stockholder Rights 38 Wants Stricter 38 Emezine 38 aproval 38 Resolve Dispute 38 Temporarily Suspends 38 Genentech Provides Update 38 Pivotal Clinical Trial 38 Voters Approve 38 Blackout Probe 38 Wood Preservative 38 Extends Term 38 Flouts 38 Ruling Upholding 38 Biotech Crops 38 Re Examine 38 Feds Approve 38 sNDAs 38 Receives Orphan Drug 38 Damages Claim 38 Esbriet pirfenidone 38 Lawmakers Propose 38 Issues Resolved 38 Deficit Cuts 38 Draws Mixed Reactions 38 orally bioavailable compound